Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy

NCT ID: NCT01112631

Last Updated: 2011-09-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

293 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-04-30

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The patients from 12 centers were included into the study. pN2 patients received PORT, pN1 patients did not. PORT was 3D-planned and consisted in 54-56 Gy in 27-28 fractions. One month after surgery, all patients completed EORTC QLQ C-30 questionnaires and had pulmonary function tests (PFT); cardiopulmonary symptoms were assessed by modified LENT-SOM score. Two years after, all patients free of disease repeated the same examinations. Changes in QLQ, LENT-SOM score and the results of PFT were compared for patients receiving and not PORT.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stage II patients post surgery

Stage II patients treated with surgery alone

No interventions assigned to this group

Stage III patients post surgery

Stage III patients treated with surgery and PORT

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* complete resection by lobectomy, bi-lobectomy or pneumonectomy of NSCLC,
* pN1 or pN2 disease,
* signed informed consent for participation in the study,
* Karnofsky Performance Status (KPS) higher than 70%.

Exclusion Criteria

* presence of distant metastases,
* N2 diagnosed before surgery in imaging and/or mediastinoscopy,
* previous radiotherapy to the chest,
* no or inadequate mediastinal nodal dissection ,
* FEV1 after surgery lower than 1.0 liter,
* any active infectious process (including fistula formation) in the chest
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute of Tuberculosis and Lung Diseases in Warsaw

UNKNOWN

Sponsor Role collaborator

The Greater Poland Centre of Lung Diseases and Tuberculosis in Poznan

UNKNOWN

Sponsor Role collaborator

The Greater Poland Cancer Centre

OTHER

Sponsor Role collaborator

Cancer Centre in Bydgoszcz

UNKNOWN

Sponsor Role collaborator

Kujawsko-Pomorskie Center of Pulmonology in Bydgoszcz

UNKNOWN

Sponsor Role collaborator

Specialized Hospital in Zdunowo - Szczecin

UNKNOWN

Sponsor Role collaborator

Regional Cancer Hospital - Szczecin

UNKNOWN

Sponsor Role collaborator

Medical University of Gdansk

OTHER

Sponsor Role collaborator

Holycross Cancer Center in Kielce

UNKNOWN

Sponsor Role collaborator

Department of Thoracic Surgery - Wrocław

UNKNOWN

Sponsor Role collaborator

Department of Radiotherapy - Olsztyn

UNKNOWN

Sponsor Role collaborator

Department of Thoracic Surgery - Łódź

UNKNOWN

Sponsor Role collaborator

Lower Silesian Oncology Center - Wroclaw

UNKNOWN

Sponsor Role collaborator

Regional Specialized Hospital -Chęciny, Czerwona Góra

UNKNOWN

Sponsor Role collaborator

Department of Thoracic Surgery - Otwock

UNKNOWN

Sponsor Role collaborator

Medical University of Łódź

OTHER

Sponsor Role collaborator

Maria Sklodowska-Curie National Research Institute of Oncology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology in Warsaw

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Krzysztof Bujko, Prof.

Role: PRINCIPAL_INVESTIGATOR

Roentgena 5, 02-781 Warsaw, Poland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

M. Sklodowska-Curie Memorial Cancer Centre

Warsaw, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

References

Explore related publications, articles, or registry entries linked to this study.

Kepka L, Bujko K. [Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice]. Pneumonol Alergol Pol. 2007;75(3):256-61. Polish.

Reference Type BACKGROUND
PMID: 17966101 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LPSG01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

QOL After SURGERY and ADJUVANT Treatment
NCT06115239 NOT_YET_RECRUITING